ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,040.38
-0.06%
Dow Jones
38,460.92
-0.11%
Gold vs US Dollar
2,316.22
-0.33%
Brent Oil
87.22
-0.39%
Bitcoin
64,336.25
-3.12%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Immupharma Plc (IMM) Share Price

IMM Immupharma Plc

2.16
-0.02 (-0.92%)
24 Apr 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Immupharma Plc LSE:IMM London Stock Exchange Ordinary Share GB0033711010 ORD 1P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.02 -0.92 2.16 2.12 2.20 2.20 2.13 2.2 733,951 15:35:21   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Finance Services  -3.81M -0.0114 -1.87 7.1M
 Type  Size  Price  Time  Units 
  68,299 2.1823 15:29:55 GBX
 
Recent News
DateTimeSource
HeadlineMore IMM News
24/04/202407:12LSEG_NONImmupharma PLC IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
19/04/202407:00LSEG_RNSImmupharma PLC Grant of Share Options
02/04/202412:52ALNCImmupharma jumps amid new IP strategy for P140 technology platform
02/04/202407:03LSEG_RNSImmupharma PLC New intellectual property strategy initiated
25/03/202412:20ALNCIncanthera says first order from skincare deal doubles
25/03/202407:25LSEG_RNSImmupharma PLC Incanthera provides Comm'l Update/Revenue F'casts
19/03/202407:00LSEG_RNSImmupharma PLC Grant of Share Options
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
07/04/202411:37PBBIMMUPHARMA - IN FINAL PHASE 3 LUPUS TRIAL TARGETING BLOCKBUSTER ($1bn+) REVENUES38,663
10/10/202213:36PBBImmupharma 1
30/09/202208:08PBB(IMM) ImmuPharma PLC boss excited by “blockbuster potential” of Lupuzor80
27/07/202214:08PBBIMMUPHARMA - Let's Talk about the Negatives390
02/06/202112:03PBB'One To Watch' Immupharma 9
20/11/202010:40PBB50 Dollars4
20/11/202010:40PBBImmuPharma - Global Potential Blockbusters & Huge Potential Upside105
20/11/202010:40PBBImmuPharma’s Lupuzor could potentially reduce coronavirus symptoms, US study say91
21/01/202014:02PBBImmune cell which kills most cancers - ONE CELL TO KILL THEM ALL16
03/04/201908:58PBBSell order14
Newsletter articles for Immupharma Plc
DateTimeNewsletterHeadline
11/6/202320:16Opportunity 4 Material GainsNudge a Blind Horse
13/2/202220:51Opportunity 4 Material GainsBracing time
15/8/202121:04Opportunity 4 Material GainsReviews: Advanced Oncotherapy on threshold of greatness
13/12/202021:56Opportunity 4 Material GainsSanta rally on ice
27/5/201922:05Opportunity 4 Material GainsA few more buyers
19/5/201923:04Opportunity 4 Material GainsBliss of ignorance
More newsletter articles
Data Downloads for IMM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Immupharma Plc
Get quick technical analysis for Immupharma Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.
Related Shares
Astrazeneca (AZN), Gsk (GSK), N4 Pharma (N4P), Fusion Antibodies (FAB)


Loading Follow Feed...

Latest Immupharma Plc Articles